journal article·2024-01-10

Immunoadjuvant-Modified Rhodobacter sphaeroides Potentiate Cancer Photothermal Immunotherapy

Mei-Ting Niu, Qi-Wen Chen, Zhu Chen, Xinhua Liu, Qian-Xiao Huang, Jun-Long Liang, Zhenlin Zhong, Han Cheng, Xian-Zheng Zhang

Nano Letters· Volume 24· Issue 1
Publisher page

Abstract

Photothermal immunotherapy has become a promising strategy for tumor treatment. However, the intrinsic drawbacks like light instability, poor immunoadjuvant effect, and poor accumulation of conventional inorganic or organic photothermal agents limit their further applications. Based on the superior carrying capacity and active tumor targeting property of living bacteria, an immunoadjuvant-intensified and engineered tumor-targeting bacterium was constructed to achieve effective photothermal immunotherapy. Specifically, immunoadjuvant imiquimod (R837)-loaded thermosensitive liposomes (R837@TSL) were covalently decorated onto Rhodobacter sphaeroides (R.S) to obtain nanoimmunoadjuvant-armed bacteria (R.S-R837@TSL). The intrinsic photothermal property of R.S combined R837@TSL to achieve in situ near-infrared (NIR) laser-controlled release of R837. Meanwhile, tumor immunogenic cell death (ICD) caused by photothermal effect of R.S-R837@TSL, synergizes with released immunoadjuvants to promote maturation of dendritic cells (DCs), which enhance cytotoxic T lymphocytes (CTLs) infiltration for further tumor eradication. The photosynthetic bacteria armed with immunoadjuvant-loaded liposomes provide a strategy for immunoadjuvant-enhanced cancer photothermal immunotherapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Cancer Research and Treatments · Immunotherapy and Immune Responses

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan 430072, P. R. China

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China

References (56)

Show source-provided references
1. 10.1126/scitranslmed.aat780710.1126/scitranslmed.aat7807 ↗
2. 10.1038/s41565-019-0567-y10.1038/s41565-019-0567-y ↗
3. 10.1038/s41568-019-0186-910.1038/s41568-019-0186-9 ↗
4. 10.1038/s41571-021-00552-710.1038/s41571-021-00552-7 ↗
5. 10.1002/advs.20210344410.1002/advs.202103444 ↗
6. 10.1007/s11426-019-9507-x10.1007/s11426-019-9507-x ↗
7. 10.1002/adma.20221017910.1002/adma.202210179 ↗
8. 10.1002/adfm.20227025410.1002/adfm.202270254 ↗
9. 10.31635/ccschem.021.20210102910.31635/ccschem.021.202101029 ↗
10. 10.1016/j.bioactmat.2021.05.03010.1016/j.bioactmat.2021.05.030 ↗
11. 10.1039/D0BM01158D10.1039/D0BM01158D ↗
12. 10.1002/anie.20180488210.1002/anie.201804882 ↗
13. 10.31635/ccschem.021.20210145810.31635/ccschem.021.202101458 ↗
14. 10.1038/nrc338010.1038/nrc3380 ↗
15. 10.2147/IJN.S24925210.2147/IJN.S249252 ↗
16. 10.1038/ncomms1319310.1038/ncomms13193 ↗
17. 10.1016/j.biomaterials.2022.12142510.1016/j.biomaterials.2022.121425 ↗
18. 10.1021/acs.nanolett.2c0050010.1021/acs.nanolett.2c00500 ↗
19. 10.1038/ncomms1296710.1038/ncomms12967 ↗
20. 10.1038/s41578-019-0108-110.1038/s41578-019-0108-1 ↗
21. 10.1002/advs.20210479310.1002/advs.202104793 ↗
22. 10.1002/anie.20200264910.1002/anie.202002649 ↗
23. 10.1002/adfm.20200974410.1002/adfm.202009744 ↗
24. 10.1002/adma.20197011910.1002/adma.201970119 ↗
25. 10.1021/acs.nanolett.1c0040810.1021/acs.nanolett.1c00408 ↗
26. 10.1002/adfm.20190980610.1002/adfm.201909806 ↗
27. 10.1002/adfm.20230272810.1002/adfm.202302728 ↗
28. 10.1016/j.addr.2022.11429610.1016/j.addr.2022.114296 ↗
29. 10.1039/D0CS01571G10.1039/D0CS01571G ↗
30. 10.1016/j.addr.2023.11469610.1016/j.addr.2023.114696 ↗
31. 10.1021/acsnano.9b0049410.1021/acsnano.9b00494 ↗
32. 10.1016/0040-4039(96)01346-910.1016/0040-4039(96)01346-9 ↗
33. 10.1002/adom.20237003410.1002/adom.202370034 ↗
34. 10.1016/j.ijhydene.2009.11.03010.1016/j.ijhydene.2009.11.030 ↗
35. 10.1186/1752-0509-7-8910.1186/1752-0509-7-89 ↗
36. 10.1263/jbb.100.48110.1263/jbb.100.481 ↗
37. 10.3390/molecules2624743710.3390/molecules26247437 ↗
38. 10.1111/1348-0421.1213410.1111/1348-0421.12134 ↗
39. 10.1111/j.1574-695X.1994.tb00499.x10.1111/j.1574-695X.1994.tb00499.x ↗
40. 10.1002/anie.19952000110.1002/anie.199520001 ↗
41. 10.1179/09680519910153165110.1179/096805199101531651 ↗
42. 10.1016/j.vaccine.2019.04.09710.1016/j.vaccine.2019.04.097 ↗
43. 10.1038/s41590-019-0368-310.1038/s41590-019-0368-3 ↗
44. 10.1038/nature0973710.1038/nature09737 ↗
45. 10.1038/ni122310.1038/ni1223 ↗
46. 10.1021/acs.nanolett.9b0003010.1021/acs.nanolett.9b00030 ↗
47. 10.1016/j.biomaterials.2021.12096410.1016/j.biomaterials.2021.120964 ↗
48. 10.1016/j.jconrel.2020.11.01310.1016/j.jconrel.2020.11.013 ↗
49. 10.1002/adma.20200345810.1002/adma.202003458 ↗
50. 10.1021/nn501130410.1021/nn5011304 ↗
51. 10.1146/annurev-immunol-032712-10000810.1146/annurev-immunol-032712-100008 ↗
52. 10.1002/advs.20200041110.1002/advs.202000411 ↗
53. 10.1111/j.1600-065X.2010.00916.x10.1111/j.1600-065X.2010.00916.x ↗
54. 10.1016/S0092-8674(01)00449-410.1016/S0092-8674(01)00449-4 ↗
55. 10.1007/s11426-022-1347-910.1007/s11426-022-1347-9 ↗
56. 10.1038/s41568-018-0070-z10.1038/s41568-018-0070-z ↗